Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NHLBI Obesity, Nutrition, and Physical Activity (ONPA) Seminar Series: Behavioral and Nutritional Considerations in Incretin-Based Obesity Treatments

Air date: Thursday, January 8, 2026, 12:00:00 PM
Time displayed is Eastern Time, Washington DC Local
iCalendar: Add event to iCalendar Add an upcoming event to your calendar.
Description: In this 1-hour virtual seminar, Michelle Cardel, Ph.D., M.S., RD, FTOS, will discuss how incretin-based medications, including semaglutide and tirzepatide, are transforming the landscape of obesity treatment. Research shows that these medications result in approximately 15–21% body weight loss in 1 year. However, incretin-based medications were intended to serve as an adjunct to behavioral modification, rather than a replacement. The behavioral and nutritional needs of patients on incretin-based obesity medications are unique, requiring a tailored approach to ensure nutritional adequacy, minimize common side effects such as nausea and constipation, and maintain lean muscle mass during rapid weight loss. Comprehensive telehealth medical weight management programs, which integrate behavioral support, have demonstrated meaningful impacts on not just weight, but overall health. This presentation will review the latest research on how behavioral programs affect a variety of outcomes for patients on a GLP-1RA medication, including diet quality, physical activity, and quality of life. If you have questions for the Dr. Cardel, please email them to ONPA@mail.nih.gov. Individuals requiring Sign Language Interpreters or other reasonable accommodations to facilitate their participation in this event should contact Susan Holbrook at susan.holbrook@nih.gov at least five (5) days prior to the commencement of the event.
Author: Michelle Cardel, Ph.D., M.S., RD, FTOS
Runtime: 1 hour